Antihypertensive Drugs Market

Antihypertensive Drugs Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

197

Base Year:

2023

Jul - 2024

Format:

Report Code:

VMR-2562

Segments Covered

By Drug Class Diuretics, ACE Inhibitors, Calcium Channel Blockers, Beta-adrenergic Blockers, Vasodilators, Others
By Type Primary Hypertension, Secondary Hypertension
By End User Retail Pharmacy, Hospital Pharmacy, E-commerce
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2023
Forecast Years:	2024 - 2032
Historical Years:	2018 - 2022
Revenue 2023:	USD 25.5 Billion
Revenue 2032:	USD 33.86 Billion
Revenue CAGR (2024 - 2032):	3.2%
Fastest Growing Region (2024 - 2032)	Asia Pacific
Largest Region (2023):	North America 4

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Antihypertensive Drugs Market - Segment Analysis
1. Overview
2. Global Antihypertensive Drugs Market, 2016 - 2028 (USD Million)
3. Global Antihypertensive Drugs Market - by Drug Class
  1. By Diuretics
  2. By ACE Inhibitors
  3. By Calcium Channel Blockers
  4. By Beta-adrenergic Blockers
  5. By Vasodilators
  6. By Others
4. Global Antihypertensive Drugs Market - by Type
  1. By Primary Hypertension
  2. By Secondary Hypertension
5. Global Antihypertensive Drugs Market - by End User
  1. By Retail Pharmacy
  2. By Hospital Pharmacy
  3. By E-commerce
6. Global Antihypertensive Drugs Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
7. Market comparative analysis
North America Antihypertensive Drugs Market - Segment Analysis
1. Overview
2. North America Antihypertensive Drugs Market, 2016 - 2028 (USD Million)
3. North America Antihypertensive Drugs Market, by Drug Class
  1. By Diuretics
  2. By ACE Inhibitors
  3. By Calcium Channel Blockers
  4. By Beta-adrenergic Blockers
  5. By Vasodilators
  6. By Others
4. North America Antihypertensive Drugs Market, by Type
  1. By Primary Hypertension
  2. By Secondary Hypertension
5. North America Antihypertensive Drugs Market, by End User
  1. By Retail Pharmacy
  2. By Hospital Pharmacy
  3. By E-commerce
6. North America Antihypertensive Drugs Market, by Country
  1. U.S.
    1. U.S. Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. U.S. Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. U.S. Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  2. Canada
    1. Canada Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. Canada Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. Canada Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  3. Mexico
    1. Mexico Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. Mexico Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. Mexico Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
Europe Antihypertensive Drugs Market - Segment Analysis
1. Overview
2. Europe Antihypertensive Drugs Market, 2016 - 2028 (USD Million)
3. Europe Antihypertensive Drugs Market, by Drug Class
  1. By Diuretics
  2. By ACE Inhibitors
  3. By Calcium Channel Blockers
  4. By Beta-adrenergic Blockers
  5. By Vasodilators
  6. By Others
4. Europe Antihypertensive Drugs Market, by Type
  1. By Primary Hypertension
  2. By Secondary Hypertension
5. Europe Antihypertensive Drugs Market, by End User
  1. By Retail Pharmacy
  2. By Hospital Pharmacy
  3. By E-commerce
6. Europe Antihypertensive Drugs Market, by Country
  1. Germany
    1. Germany Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. Germany Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. Germany Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  2. UK
    1. UK Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. UK Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. UK Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  3. France
    1. France Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. France Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. France Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  4. Spain
    1. Spain Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. Spain Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. Spain Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  5. Italy
    1. Italy Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. Italy Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. Italy Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  6. BENELUX
    1. BENELUX Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. BENELUX Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. BENELUX Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  7. Rest of Europe
    1. Rest Of Europe Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. Rest Of Europe Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. Rest Of Europe Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
Asia Pacific Antihypertensive Drugs Market - Segment Analysis
1. Overview
2. Asia Pacific Antihypertensive Drugs Market, 2016 - 2028 (USD Million)
3. Asia Pacific Antihypertensive Drugs Market, by Drug Class
  1. By Diuretics
  2. By ACE Inhibitors
  3. By Calcium Channel Blockers
  4. By Beta-adrenergic Blockers
  5. By Vasodilators
  6. By Others
4. Asia Pacific Antihypertensive Drugs Market, by Type
  1. By Primary Hypertension
  2. By Secondary Hypertension
5. Asia Pacific Antihypertensive Drugs Market, by End User
  1. By Retail Pharmacy
  2. By Hospital Pharmacy
  3. By E-commerce
6. Asia Pacific Antihypertensive Drugs Market, by Country
  1. China
    1. China Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. China Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. China Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  2. Japan
    1. Japan Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. Japan Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. Japan Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  3. India
    1. India Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. India Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. India Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  4. South Korea
    1. South Korea Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. South Korea Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. South Korea Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  5. South East Asia
    1. South East Asia Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. South East Asia Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. South East Asia Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. Rest of Asia Pacific Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. Rest of Asia Pacific Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
Latin America Antihypertensive Drugs Market - Segment Analysis
1. Overview
2. Latin America Antihypertensive Drugs Market, 2016 - 2028 (USD Million)
3. Latin America Antihypertensive Drugs Market, by Drug Class
  1. By Diuretics
  2. By ACE Inhibitors
  3. By Calcium Channel Blockers
  4. By Beta-adrenergic Blockers
  5. By Vasodilators
  6. By Others
4. Latin America Antihypertensive Drugs Market, by Type
  1. By Primary Hypertension
  2. By Secondary Hypertension
5. Latin America Antihypertensive Drugs Market, by End User
  1. By Retail Pharmacy
  2. By Hospital Pharmacy
  3. By E-commerce
6. Latin America Antihypertensive Drugs Market, by Country
  1. Brazil
    1. Brazil Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. Brazil Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. Brazil Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  2. Argentina
    1. Argentina Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. Argentina Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. Argentina Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  3. Rest of Latin America
    1. Rest of Latin America Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. Rest of Latin America Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. Rest of Latin America Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
Middle East & Africa Antihypertensive Drugs Market - Segment Analysis
1. Overview
2. Middle East & Africa Antihypertensive Drugs Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Antihypertensive Drugs Market, by Drug Class
  1. By Diuretics
  2. By ACE Inhibitors
  3. By Calcium Channel Blockers
  4. By Beta-adrenergic Blockers
  5. By Vasodilators
  6. By Others
4. Middle East & Africa Antihypertensive Drugs Market, by Type
  1. By Primary Hypertension
  2. By Secondary Hypertension
5. Middle East & Africa Antihypertensive Drugs Market, by End User
  1. By Retail Pharmacy
  2. By Hospital Pharmacy
  3. By E-commerce
6. Middle East & Africa Antihypertensive Drugs Market, by Country
  1. GCC Countries
    1. GCC Countries Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. GCC Countries Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. GCC Countries Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  2. South Africa
    1. South Africa Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. South Africa Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. South Africa Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Antihypertensive Drugs Market, By Drug Class
      1. By Diuretics
      2. By ACE Inhibitors
      3. By Calcium Channel Blockers
      4. By Beta-adrenergic Blockers
      5. By Vasodilators
      6. By Others
    2. Rest of Middle East & Africa Antihypertensive Drugs Market, By Type
      1. By Primary Hypertension
      2. By Secondary Hypertension
    3. Rest of Middle East & Africa Antihypertensive Drugs Market, By End User
      1. By Retail Pharmacy
      2. By Hospital Pharmacy
      3. By E-commerce
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Novartis AG.
2. AstraZeneca plc
3. Lupin
4. Daiichi Sankyo Company
5. Limited
6. Johnson & Johnson
7. Pfizer Inc.
8. Sun Pharmaceutical Industries Ltd.
9. SANOFI
10. Boehringer Ingelheim International GmbH
11. Merck & Co. Inc
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 01-Aug-2024

Antihypertensive Drugs Market to Reach USD 33.86 Billion by 2032

FAQ

Frequently Asked Question

What is the global demand for Antihypertensive Drugs in terms of revenue?

The global Antihypertensive Drugs valued at USD 25.5 Billion in 2023 and is expected to reach USD 33.86 Billion in 2032 growing at a CAGR of 3.2%.

Which are the prominent players in the market?

The prominent players in the market are Novartis AG., AstraZeneca plc, Lupin, Daiichi Sankyo Company, Limited, Johnson & Johnson, Pfizer Inc., Sun Pharmaceutical Industries Ltd., SANOFI, Boehringer Ingelheim International GmbH, Merck & Co. Inc.

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 3.2% between 2024 and 2032.

What are the driving factors fueling the growth of the market.

The driving factors of the Antihypertensive Drugs include

Which region accounted for the largest share in the market?

North America 4 was the leading regional segment of the Antihypertensive Drugs in 2023.

Antihypertensive Drugs Market

Antihypertensive Drugs Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Antihypertensive Drugs in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Vantage Market Research

Products & Services

Media

Contact Us

Antihypertensive Drugs Market

Antihypertensive Drugs Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Antihypertensive Drugs in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Antihypertensive Drugs Market

Vantage Point Interactive Dashboard